Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary
Journal of Cellular Signaling · 23.06.2026 · 7 (2) · 64
DOI: 10.33696/signaling.7.153 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Cellular Signaling, online erschienen am 23.06.2026. Verfasst von Lucas Francis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City University College of Osteopathic Medicine, Kansas City, MO 64106, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Kansas City University College of Osteopathic Medicine, Kansas City, MO 64106, USA.
- Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Francis, L., & Butler, M. G. (2026). Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary. Journal of Cellular Signaling, 7(2), 64. https://doi.org/10.33696/signaling.7.153
Vancouver
Francis L, Butler MG. Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary. Journal of Cellular Signaling. 2026;7(2):64. doi:10.33696/signaling.7.153
BibTeX
@article{Francis2026,
author = {Francis, Lucas and Butler, Merlin G},
title = {Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary},
journal = {Journal of Cellular Signaling},
year = {2026},
volume = {7},
number = {2},
pages = {64},
doi = {10.33696/signaling.7.153}
}
EUVIMED